Seqirus Protocol

1234567891011121314151617181920212223
Across
  1. 5. Collected from Day 1 to Day 7
  2. 6. Post injection assessment time
  3. 7. Primary method to control influenza
  4. 9. Conducted on Day 8 to review eDiary data
  5. 12. Decided to be ineligible for study participation
  6. 14. Joint pains
  7. 15. Measured during physical examination
  8. 17. Criteria for temporary delay
  9. 19. Any change or departure from the study design or procedures
  10. 21. Study design
  11. 22. Route of IP administration
  12. 23. Used by site staff to collect data from each subject
Down
  1. 1. Person who decides if subjects can be withdrawn from study
  2. 2. Assessed in the overall study population
  3. 3. A visit to the study site
  4. 4. Duration of the study for each subject
  5. 8. Testing done on blood samples
  6. 10. Period from Day 1 to Day 29
  7. 11. Type of sample collected only from WOCBP
  8. 13. Type of sample collected from all subjects
  9. 16. Failure to enter and transmit eDiary data
  10. 18. Period from Day 30 to Day 181
  11. 20. Informed consent needs to be within ____ of Day 1